-
December 23, 2019
Renal Cell Cancer Treatment: The Old, the Almost Old, and the New
Emma Shtivelman, PhDClear cell renal cell cancer (ccRCC) is the predominant type of kidney cancer, accounting for 70% to 75% of all kidney cancers. Here, I outline the current treatment landscape for ccRCC, highlighting what’s new and what’s on the horizon. Surgical… Read more »
-
September 1, 2020
Renal Cell Carcinoma—An OverviewBookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD, who notes:
There are now many precision oncology treatments for the most common type of kidney cancer, renal cell carcinoma, which represents about 3% of all potentially lethal cancers in America. This summary from Medscape details all the traditional treatment approaches, as well as newer considerations.
.
-
August 7, 2020
FDA Approves Merck’s Keytruda, Foundation Medicine CDx for TMB-High Solid TumorsBookmark
George Lundberg, MDArticle from GenomeWeb curated by Editor in Chief George Lundberg, MD, who notes:
The U.S. Food and Drug Administration (FDA) has approved the drug pembrolizumab (brand name Keytruda) for solid tumors based solely on whether they have a high tumor mutational burden—a high number of changes in the DNA of the cancer cells.
Go to full article published by GenomeWeb.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
December 13, 2019
New Standard of Care for Metastatic Renal Cell CarcinomaBookmark
George Lundberg, MDArticle from Medscape curated by Editor in Chief George Lundberg, MD, who notes:
This piece describes huge improvements in the standard of care and outcomes from combo therapy in metastatic renal cell carcinoma.
Go to full article published by Medscape.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
December 2, 2019
Deciding on the Ideal First-Line Treatment for Rare and Advanced Kidney CancersBookmark
George Lundberg, MDArticle from Targeted Oncology curated by Editor in Chief George Lundberg, MD, who notes:
In recent clinical trials, the drug cabozantinib is being found to greatly increase progression-free survival.
Go to full article published by Targeted Oncology.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
November 12, 2019
Microwave Ablation Feasible for cT1b Renal Cell CarcinomaBookmark
George Lundberg, MDArticle from Renal and Urology News curated by Editor in Chief George Lundberg, MD, who notes:
Microwave ablation has been shown to be a viable alternative to both radical and partial nephrectomy for kidney cancers that measure less than 7 cm in diameter. Outcomes for the two approaches are comparable.
Go to full article published by Renal and Urology News.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
Show More

Ellen
Breast cancer patient

Tony Blau, MD
University of Washington
Cancer affects many aspects of life, whether you’re newly diagnosed, in the midst of treatment, or in follow-up care. Learn about ways to maintain quality of life, such as palliative care and managing side effects.
-
October 14, 2019
Pediatric Palliative Care: A Specialty Comes of Age
For a child with cancer, palliative care can provide much-needed relief from stress and symptoms—for the patient and their family alike. Palliative care is given alongside cancer treatment, and is not synonymous with “end-of-life” care. In fact, anyone with a… Read more »
-
February 11, 2020
‘Impressed With Impact’ of Ketamine in Cancer Palliative CareBookmark
George Lundberg, MDArticle from Medscape curated by Editor in Chief George Lundberg, MD, who notes:
Depression is, for obvious reasons, common in patients with advanced cancer. The old, inexpensive drug ketamine—already approved for medical use by the U.S. Food and Drug Administration (FDA)—seems rapidly effective, according to small studies.
Go to full article published by Medscape.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
October 7, 2019
Emphasizing Oncogeriatrics
With:A Q&A with Nicolò Matteo Luca Battisti, MD, Medical Oncologist at The Royal Marsden NHS Foundation Trust, London, United Kingdom, and Chair of the Young Interest Group of the International Society of Geriatric Oncology (SIOG); nicolo.battisti@gmail.com Q: Everyone knows that… Read more »
-
December 3, 2018
Best Uses of Physical Medicine and Rehabilitation in Patients with Cancer
With:A Q&A with Val Jones, MD, Medical Director of Admissions, Saint Luke’s Rehabilitation Institute, Spokane, WA Originally published February 1, 2017 Q: Your principal practice in Spokane, Washington is physical medicine and rehabilitation (PM&R). What do you find to be… Read more »
-
September 14, 2018
Huge Progress in Palliative Care
With:A Q&A with Diane E. Meier, MD, FACP, Director, Center to Advance Palliative Care; Professor of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai; New York, NY; diane.meier@mssm.edu Originally published November 8, 2017 Q: You wrote in… Read more »
-
July 23, 2018
Cancer Pain and the Opioid Epidemic
George Lundberg, MDA Q&A with Kevin Sevarino, MD, PhD, President-elect of the American Academy of Addiction Psychiatry and Consulting Psychiatrist at Gaylord Hospital in Wallingford, CT Q: Opioid abuse, addiction, and overdose are huge American problems right now. Many cancer patents experience chronic… Read more »
Show More
Learn more about what’s new in advanced cancer research and treatment, including screening and statistics, using artificial intelligence to improve treatment, and other new horizons in cancer care.
-
November 10, 2020
How to Learn About Cancer in a Classroom: Shaping Compassionate Doctors
With:The patients and caregivers we serve here at Cancer Commons rely on their doctors to provide expert, compassionate care. Building the skills to give such care can begin early in a doctor’s education. Here, for a change of pace, our… Read more »
-
September 9, 2020
Is Cancer the Best Way to Die?
With:In 2014, the prestigious medical research journal The BMJ published a controversial piece called “Dying of cancer is the best death.” Here, our Curious Dr. George asks the author of that piece, Richard Smith, CBE, FMedSci, if and how his thoughts… Read more »
-
August 21, 2020
The Power of Precision Medicine is Exemplified by Tempus
With:Tempus—a tech company & partner of Cancer Commons—empowers doctors to make data-driven decisions for their patients in real time. Learn how.
-
June 29, 2020
Cancer Screening Programs Influence Incidence and Causes of Cancer DeathsBookmark
Lola Rahib, PhDArticle from ASCO Daily News curated by Director of Scientific and Clinical Affairs, Lola Rahib, PhD.
In collaboration with MD Anderson Cancer Center and the Pancreatic Cancer Action Network, Cancer Commons presented new research at the American Society of Clinical Oncology (ASCO)’s virtual 2020 meeting. The findings show that, by 2040, we will likely see notable changes in which cancer types are most common and which are most deadly, highlighting the influence of cancer screening programs. This research was led by Dr. Rahib at Cancer Commons.
Go to full article published by ASCO Daily News.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
May 30, 2020
What Have I Learned in More Than Half a Century in Cancer Medicine?Bookmark
George Lundberg, MDArticle from The ASCO Post curated by Editor in Chief George Lundberg, MD, who notes:
“Patients with cancer need to be embraced with love and compassion. They need caring beyond medicine.”Go to full article published by The ASCO Post.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
April 27, 2020
The Challenges of Using Artificial Intelligence to Improve Cancer Treatment
With: Razelle Kurzrock, MDJeff Shrager, PhDIn a previous post, CureMatch co-founder Razelle Kurzrock, MD, told us all about her company’s artificial intelligence (AI) platform that matches patients with treatments based on their cancer’s molecular profile. Here, AI expert Jeff Shrager, PhD, responds, and Kurzrock offers… Read more »
Show More
The coronavirus pandemic presents unprecedented challenges to cancer patients. We can help you understand how COVID-19 might impact your treatment and other aspects of your cancer care.
-
June 10, 2020
How I Cope with the Tsunami of Cancer and COVID-19 Info
With: Kevin Knopf, MD, MPHOncologists worldwide face the challenge of staying on top of the latest treatments, research findings, and other information that could help them treat their patients more effectively. Now, they must do so in the context of COVID-19. Here, our Curious… Read more »
-
August 7, 2020
Clinical Trials Gone VirtualBookmark
George Lundberg, MDArticle from GenomeWeb curated by Editor in Chief George Lundberg, MD, who notes:
During the COVID-19 pandemic, some clinical trials have gone virtual.
Go to full article published by GenomeWeb.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
May 20, 2020
How the Coronavirus Pandemic Impacts Cancer Care: Our Survey Results
With: Lola Rahib, PhDThe ongoing COVID-19 pandemic presents unprecedented challenges to cancer patients. Many have experienced changes to their care, and some face increased risk of infection or worse prognosis if they are infected. In partnership with the company xCures, Cancer Commons is… Read more »
-
April 14, 2020
What Cancer Patients and Caregivers Need to Know About the Coronavirus Disease
In light of the ongoing coronavirus disease (COVID-19) pandemic, cancer patients may be wondering how their medical situation affects their vulnerability to infection and other ways the pandemic will affect their cancer care. What is the coronavirus disease? COVID-19 (the… Read more »
-
April 3, 2020
How to Beat COVID-19 with Real-Time, Real-World Data
With: Mark Shapiro, PhDAs the COVID-19 pandemic continues, researchers around the world are working quickly to develop strategies to treat and prevent this disease. In partnership with the company xCures, Cancer Commons is studying how COVID-19 impacts cancer patients. Meanwhile, xCures has launched… Read more »
-
March 17, 2020
These Underlying Conditions Make Coronavirus More Severe, and They’re Surprisingly CommonBookmark
George Lundberg, MDExcerpt from a National Geographic article:
“For now, the sole intervention for vulnerable cancer patients is social distancing and enhanced hygiene practices for their family and health care workers.”
Go to full article published by National Geographic.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
Show More